Table 3

Procedural characteristics and outcome of the original and propensity-matched cohort

Procedural characteristicsBefore propensity score matchingAfter propensity score matching
Control cohort (n=902)CVP cohort (n=11)P valueControl cohort (n=16)CVP cohort (n=8)P value
Onset to groin puncture, min (median; Q1, Q3)230.0 (152.5, 311.5)125.0 (100.0, 173.0)0.007284.0 (215.0, 490.5)171.5 (136.3, 178.3)0.039
Groin puncture to final TICI, min (median; Q1, Q3)42.0 (27.0, 65.5)45.0 (27.3, 66.3)0.98945.0 (25.5, 55.0)40.0 (25.8, 65.5)0.969
Onset to final TICI, min (median; Q1, Q3)278.0 (202.0, 354.8)177.0 (145.5, 198.0)0.003419.0 (274.0, 613.0)195.0 (146.0, 201.0)0.028
Median number of passes (median; Q1, Q3)2 (1, 3)2 (1, 3)0.2052 (1, 2.3)2.0 (1, 2)0.819
Recanalization TICI (%)
2a73 (8.6)1 (9.1)1 (6.2)0 (0.0)
2b302 (35.4)1 (9.1)7 (43.8)1 (12.5)
3367 (43.0)6 (54.5)7 (43.8)5 (62.5)
Complications
Clot migration (%)17 (1.9)0 (0.0)0 (0.0)0 (0.0)
SAB (%)13 (1.4)0 (0.0)0 (0.0)0 (0.0)
Vasospasm (%)22 (2.4)0 (0.0)0 (0.0)0 (0.0)
Dissection/perforation (%)22 (2.4)0 (0.0)0 (0.0)0 (0.0)
sICH (%)66 (7.3)2 (22.2)0.2920 (0.0)2 (28.6)0.152
Outcome
mRS score at 90 days (median; Q1, Q3)4.0 (2.0, 6.0)5.0 (3.50, 6.0)0.2745.00 (4.0, 6.0)5.50 (3.3, 6.0)1.000
Mortality at 90 days (%)209 (26.5)5 (45.5)0.2856 (37.5)4 (50.0)0.884
Good outcome
(%)
244 (30.9)2 (18.2)0.5612 (12.5)2 (25.5)0.846
  • Categorical variables are shown as absolute numbers and percentages. Continuous variables are described by mean±SD or median and the first and third quartile (Q1, Q3). Good outcome is defined as mRS score at 90 days ≤2. Percentages are given for patients with the full availability of the investigated variable.

  • CVP, cardiovascular procedure; mRS, modified Rankin Scale; SAB, subarachnoid bleeding; sICH, symptomatic intracranial hemorrhage; TICI, Thrombolysis in Cerebral Infarction.